While multiple lines of evidence support a central role of CD8+ and CD4+ T cells in the control of HCV infection, the role of antibodies in resolving infection and, by extension, their potential protective value in vaccine-elicited responses, has been less clear. This evidence concerns the gene CD4 and infection.